This aligns with prior observations indicating anti-tumoral properties of immature neutrophil populations.2Sellhi neutrophils also exhibited a distinct interferon (IFN) signature, including interferon regulatory factor 1 (IRF1), a crucial driver of their anti-tumor phenotype, and appeared to be essential for the successful therapy (Fig. 1). Here, IRF1 is linked to neoplasm.